The Science of IVM
Oocyte in vitro maturation (IVM) makes use of oocytes from patients that have received minimal or no gonadotrophin stimulation. Whilst this brings many advantages to patients, this typically means oocytes are collected from small-medium sized (4-12 mm) antral follicles. These oocytes are under-devel...
Main Author: | Robert GILCHRIST |
---|---|
Format: | Article |
Language: | English |
Published: |
World Scientific Publishing
2022-09-01
|
Series: | Fertility & Reproduction |
Online Access: | https://www.worldscientific.com/doi/10.1142/S2661318222740097 |
Similar Items
-
Novel Oocyte-Secreted Factors Improve Mouse IVM Outcomes
by: Dulama RICHANI, et al.
Published: (2022-09-01) -
Application of Ex-Vivo In Vitro Maturation (IVM) to Fertility Preservation in Cancer Patients
by: Robert B. GILCHRIST, et al.
Published: (2022-09-01) -
Clinical IVM in Australia: Results and Future Prospects
by: Roger HART
Published: (2022-09-01) -
IN VITRO MATURATION OF OOCYTES (IVM) IN PCOS PATIENTS
by: Vilma Kovač, et al.
Published: (2018-02-01) -
IVM: What are the RCTs Telling Us So Far?
by: Johan E.J. SMITZ
Published: (2022-09-01)